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ABSTRACT  
Background: Bare metal stents may cause complications like fibrous encapsulation, 
granulation and tracheal stenosis. We investigated the behavior of three commercially 
available stents in vivo (rabbits) and in vitro (co-culture of those stents with epithelial and 
fibroblast cell lines). Also, we investigated whether development of tracheal stenosis could 
be predicted by any biological marker. 
 
Methods: The tracheae of 30 rabbits were implanted with either nitinol stents, with or 
without paclitaxel elution, or a cobalt-based stent. An additional ten rabbits underwent mock 
implantation (controls). Serial peripheral venous blood samples were taken throughout the 
study, and several cytokines measured. Animals were euthanized on day 90, with immediate 
tracheal endoscopy and lavage performed, then necropsy.  
 
Results: Rabbits with cobalt-based stent exhibited more inflammation and the highest 
stenosis incidence, with reduced survival. Both in vivo and in vitro, this stent induced higher 
IL-8 levels than nitinol stents. Most important, presence of stent-induced tracheal stenosis 
was closely associated to increase of IL-8 expression in blood just one day after tracheal 
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stent implantation: a 1.19-fold increase vs. baseline had 83% sensitivity, 83% specificity, 
77% positive predictive value, 88% negative predictive value and 83% accuracy to predict 
development of stenosis.  
Conclusions: The cobalt-based stent had the highest incidence of tracheal inflammation and 
stenosis. On the other hand, the paclitaxel-eluting nitinol stent did not prevent those 
complications, and provoked a marked reaction compared with the bare nitinol stent. Early 
increase of IL-8 expression in blood after stent implantation could predict development of 
tracheal stenosis in rabbits. Abstract  
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INTRODUCTION  
Tracheal stents are widely used to treat malignant and benign tracheal stenoses not suitable 
for surgery (1, 2). Silicone stents are frequently used in benign conditions, but require rigid 
bronchoscopy and general anaesthesia (3, 4). Moreover, mucus retention and infections are 
serious complications with this stent. On the other hand, an increasing array of expandable 
metallic stents is available, which can be inserted into the airway using a flexible 
bronchoscope or under fluoroscopy and then expanded to the required diameter. However, 
most metallic stents are associated with migration, restenosis, granulation tissue, re-
epithelisation and deep fibrous encapsulation, which make stent removal risky or impossible 
(5-10).  
 
Drug-eluting stents (DESs) are platforms with deliver anti-proliferative, anti-thrombogenic, 
anti-inflammatory, or immunosuppressive drugs. Among anti-proliferative drugs, sirolimus 
(11), everolimus (11-13), and paclitaxel (14, 15) have all been widely used. DESs inhibit 
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cell proliferation (16-18), and there are theoretical reasons as to why they can be 
advantageous in the trachea. In this context, research aimed at the prevention of obstruction 
or fibrotic encapsulation is crucial.  
 
Together with the biological effects associated with the stent composition itself, radial and 
shear stress forces would have a marked influence on the reaction patterns of the 
tracheobronchial wall to metallic stents (19). We designed an in vivo and in vitro study, 
aiming to investigate whether metallic stents (including paclitaxel-eluting stents) induce 
different tissue reactions. Rabbits were implanted with different stents, which were also co-
cultured with human respiratory epithelial and fibroblast cell lines. Also, we investigated 
whether development of tracheal stenosis could be predicted early by any of the markers 
included in the study.  
 
METHODS  
In vivo study 
Thirty adult female New Zealand rabbits were randomly assigned (ten animals per stent) to 
receive a paclitaxel-eluting (dose delivery 3 µg/mm2) nitinol stent (Zilver PTX, Cook 
Medical, Bjaeverskov, Denmark), a bare nitinol stent (Zilver Flex, Cook Medical, 
Bjaeverskov, Denmark), or a cobalt-based super alloy stent (Wallstent, Boston Scientific, 
Natick, MA, USA). The stents were deployed percutaneously under general anaesthesia and 
fluoroscopic guidance. Computed tomography (CT) tracheal studies were performed under 
sedation 30 and 90 days after stent deployment as previously published by our Group (20). 
Parameters assessed in the CT study were: maximum tracheal lumen stenosis in an axial 
view (%), stenosis length in a sagittal view (mm), and detection of image compatible with 
granulomas (present or absent). 
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All animals were observed for any sign of respiratory distress or deterioration in general 
health during the 90-day duration of this experiment. Serial peripheral venous blood samples 
were taken throughout the study, and animals were euthanized on day 90 by intravenous 
pentobarbital injection, followed by tracheoscopy, tracheal lavage, and necropsy performed. 
The following endoscopic aspects were evaluated by two independent reviewers; tracheal 
stenosis, granulation tissue (polyploid-like lesions), re-epithelisation covering the stent, 
fibrous reactions (fibrous bands), inflammation, and secretions in the tracheal lumen (Figure 
1).  
 
The expression of pro-inflammatory (IL-8) and pro-fibrotic cytokines (bFGF, TGFβ and 
VEGF) was analysed from peripheral venous blood and tracheal lavage samples using 
reverse transcription quantikine PCR (RT-qPCR). RNA was isolated using the using High 
Pure RNA isolation (Roche Mannheim, Germany) cDNA was synthesized using an iScript 
cDNA synthesis kit (Bio-Rad, Hercules, CA, USA). RT-qPCR was performed using the 
Stratagene Mx3500 apparatus. β-actin expression was used as an internal control with which 
to normalize target gene expression. 
 
Animal care protocols were in compliance with European Communities Council Directive 
(86/609/EEC), with prior approval from our local Ethics Committee. 
 
In vitro study 
MRC-5 (human lung fibroblast cell line) cells were obtained from the European Collection 
of Cell Culture (ECACC, Salisbury, UK); Nuli-1 cells (human airway epithelial cell line) 
were purchased from the American Type Culture Collection (ATCC, Rockville, USA). 
MRC-5 and Nuli-1 were cultured following the manufacturer’s instructions. Cells were 
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seeded in 3.3 cm2 wells (Nunc, Roskilde, Denmark) and co-cultured with each stent type for 
21 days. Cells cultured without stents served as controls. Each experiment was repeated six 
times. Culture medium was replaced every three days, with supernatants harvested, 
aliquoted, and then stored at -80ºC. Morphological changes in cells were examined by 
inverted fluorescence microscopy (Zeiss Axiovert 25, Carl Zeiss Co. Oberkochen, 
Germany). Cell viability determined by trypan blue dye exclusion (Sigma, GmbH, 
Germany.  IL-8, VEGF, bFGF, and TGF-β1 levels in culture supernatants were measured by 
ELISA (R&D System, Minneapolis, MN, USA), according to the manufacturer’s 
recommendations.  
 
Statistical analysis 
Kaplan-Meier with log-rank (Mantel-Cox) analysis was performed for comparisons of 
survival. Following normality testing, the student’s t-test for independent samples or 
analysis of variance (ANOVA, with Bonferroni post-hoc test) was used to compare cytokine 
levels between groups. For non-parametric data, the Mann Whitney U or Kruskal–Wallis 
tests were applied. For correlations, the Pearson r or Spearman rho coefficients were used, 
depending on sample characteristics. ROC analysis was used to investigate performance of 
different parameters in predicting presence of tracheal inflammation or stenosis, and 
comparisons were made by chi-square test. 
Two-tailed p values < 0.05 were considered to be significant. Data processing and statistical 
analyses were performed using SPSS Statistics 20 for Windows. 
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RESULTS 
In vivo analyses   
There were no immediate deaths or major complications associated with the procedure; a 
100% technical success rate was achieved for stent implantation.  
 
Tracheoscopy data 
All tracheoscopy findings are presented in Table 1.  
Survival was significantly shorter than controls for rabbits implanted with the Wallstent 
stent (Figure 2A). Short survival was associated to stent-related stenosis (Figure 2B), and 
those animals had to be euthanized before the experimental deadline. 
 
Stenosis. The highest incidence of stenosis was observed with Wallstent group, and less 
stenosis was recorded for Zilver Flex (Table 1); nevertheless, the DES Zilver PTX was 
associated with the most severe stenosis in many cases. Stenosis correlated directly with the 
presence of inflammation (r=0.756, p<0.001), and fibrous reaction (r=0.521, p=0.002), and 
was inversely correlated with survival following stent implantation (r= -0.404, p=0.02). 
Most important, stenosis was closely associated to increase of IL-8 expression in blood just 
one day after tracheal stent implantation: a 1.19-fold increase vs. baseline had 83% 
sensitivity, 83% specificity, 77% positive predictive value, 88% negative predictive value 
and 83% accuracy to predict development of tracheal stenosis. 
 
Granulation tissue. Granulation tissue was observed for all three stent groups, with no 
significant differences between them. The Zilver PTX was the only stent for which a 
statistically significant number of granulomas arose in the area underlying the stent, 
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compared with more proximal or distal stent locations, which were more commonly seen for 
the Wallstent group.  
 
Re-epithelisation covering the stent. Re-epithelisation occurred for all animals implanted 
with the nitinol stents, irrespective of drug delivery; only partial re-epithelisation occurred 
for the Wallstent group. Of the nitinol stents used, re-epithelisation was most prominent for 
the Zilver PTX group. 
 
Fibrous encapsulation. Fibrosis was particularly prominent in rabbits with the Zilver PTX 
stent, compared with other stents (p<0.01). This adverse effect correlated closely with the 
extent of re-epithelisation (r=0.687, p<0.001), tracheal stenosis (r=0.521, p=0.002), and 
inflammation (r=0.48, p=0.004).  
 
Inflammation. Inflammation was evident for all three stent test groups, and was most severe 
for the Wallstent (85.7%) versus other groups (62.5 % for Zilver PTX; 22.2 % for Zilver 
Flex).  
 
Cytokine expression in tracheal lavage and peripheral blood samples  
Pro-inflammatory markers. Rabbits with stents expressed a higher tracheal lavage IL-8 
mRNA than controls (Figure 3A). Il-8 mRNA levels in blood are depicted in Figure 3B. 
When compared with baseline values, the mean IL-8 mRNA-folds at day 1 were 4.49 for 
Wallstent, 2.82 for Zilver Flex, 2.53 for Zilver PTZ and 0.9 for controls (p=0.029). The 
single highest tracheal lavage IL-8 mRNA expression (236-fold vs. control) was recorded in 
a rabbit fitted with a Wallstent that survived only 16 days; this animal had the most severe 
tracheal inflammation, granulation, and secretions retention.   
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Pro-fibrotic gene expression. Tracheal lavage bFGF mRNA levels were lower for all stent 
groups versus controls (p<0.01) (Figure 3C), but they were higher than controls in blood. 
However, they decreased throughout the study (Figure 3D) (see Discussion). Tracheal 
lavage TGFβ and VEGF mRNA levels revealed no significant differences between groups 
(data not shown). 
 
In vitro analyses   
Greater proliferation was noted for the Nuli-1 control cultures versus co-cultures with stents 
(Figure 4A). Conversely, MRC-5 fibroblasts showed a potent proliferative response around 
the Wallstent and Zilver Flex stents (Figure 4B). For either cell type, no viable cells could 
be observed by day 15 co-culture with paclitaxel-delivering stents. When IL-8 levels were 
normalised to total cell number (IL-8/total cell number ratio), Nuli-1 cells cultured with the 
Wallstent had the highest IL-8 levels in the first few days of culture (Figure 4C). The 
normalised data showed more bFGF expression in Nuli-1 stent co-cultures versus controls 
(Figure 4E).  
 
DISCUSSION 
Stenosis is the hardest problem associated with tracheal stent implantation, and rabbits with 
the cobalt-based stent had the highest overall incidence in our study. This adverse event was 
unexpectedly more severe in animals implanted with the paclitaxel-eluting stent. According 
to serial CT examinations that were published previously by our Group (19), stenosis 
progressed from day 30 to 90 in nitinol stents (with and without paclitaxel delivery), but not 
in the cobalt-based alloy stent, which provoked earlier stenosis, subsequently with more 
early deaths in rabbits. 
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Tracheal stenosis was closely associated to increase of IL-8 expression in blood just one day 
after tracheal stent implantation, with good sensitivity, specificity and accuracy to predict 
development of stent-induced stenosis in our rabbit study. The question on the mechanisms 
involved in this systemic IL-8 increase remains open, but it is likely that presence of strong 
local inflammation in the trachea induces a systemic inflammation also. Other unknown 
mechanisms, like release of the metallic components, unknown so far, might also be invoked 
(see below). If extrapolated into humans, our findings would imply that development of 
stent-induced tracheal stenosis can be predicted when a strong early systemic inflammation 
is observed after stent placement, and adequate treatment could then be applied to prevent 
this complication. 
 
On histopathologic examination, the paclitaxel-eluting stent did not behave as expected, and 
it caused destruction of the epithelium and tracheal structure in seven of the animals (70%), 
with adherence to surrounding tissue. The higher degree of tracheal stenosis observed in the 
Zilver PTX versus Zilver Flex group (which has the same pattern design and nickel-titanium 
alloy composition, but without drug delivery) suggests a causal role for paclitaxel. Our 
findings suggest that paclitaxel at high concentrations is highly injurious to tracheal tissue. 
While these concentrations might be adequate to prevent neo-intimal hyperplasia following 
intravascular insertion (21, 22), where blood flow clears a portion of the drug delivered, 
effective clearing is unlikely to occur in the trachea, since the natural mucociliary clearing 
mechanism can be impaired by stent insertion. Moreover, the lipophilic nature of paclitaxel 
might enhance cellular uptake, thereby increasing cytotoxicity with subsequent destruction 
of the normal epithelium, as we described previously (20).  
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Re-epithelisation implies a complete covering of the stent that, together with deep fibrous 
encapsulation, makes stent removal risky or even impossible. The intensity of fibrosis 
correlated with re-epithelisation, and both were more prominent for the paclitaxel-delivering 
stent. Fibrosis correlated also with the degree of inflammation and stenosis, which suggests 
that a complex process involving tissue injury and inadequate repair takes place in rabbits 
following stent insertion (23), especially with paclitaxel-delivering stents.  
 
Inflammation was more prominent in the Wallstent group, followed by Zilver PTX, and 
correlated directly with stenosis, granulation tissue, and fibrosis. Moreover, the Wallstent 
group showed the highest IL-8 production in our in vivo and in vitro study. 
 
As opposed to IL-8, all stent groups had bFGF mRNA downregulated in tracheal lavage 
samples compared to controls (Figure 3C). However tracheal lavage bFGF correlated 
positively with survival in our study, which emphasizes the protective role played by this 
cytokine during tissue injury and repair (24). It is important to note that according to some 
studies bFGF expression is particularly high in the early phases of granulation tissue 
formation, and then gradually decreases in the mature phase of post-intubation tracheal 
stenosis (25), which is compatible with our findings in blood samples in our study (Figure 
3D). 
 
As with other lesions, granulation tissue formation was higher for the Wallstent group, 
especially in areas proximal or distal to the stents. Since all stents had the same size (8 x 40 
mm), the differences found in biologic reactions to the stents were probably related to their 
different geometric structures and/or composition. The Wallstent was made of stainless steel 
filaments in the past and, more recently, an alloy containing cobalt, chromium, nickel, 
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molybdenum and manganese, amongst other elements. The filaments are organized in a 
crisscross pattern and have an open strut structure at both the proximal and distal ends, 
which may be responsible for the tension-associated lesions observed at those locations. On 
the other hand, Zilver Flex and PTX are made of a nickel-titanium (nitinol) super alloy with 
memory shape and a zigzag structure, with less tension exerted on the tracheal wall. By 
building a rabbit trachea numerical model, our Group was able to analyse the behaviour of 
the trachea before and after deployment of Zilver Flex and Wallstent stents (the same that 
were used for this present study) and thus showed that tensile stent-associated forces may 
lead to a greater tracheal epithelium response within the stented region  (26).  
 
Role of the in vitro study. Our in vivo rabbit study involved both biological effects derived 
from the composition of the stent itself and mechanical forces exerted by the stent on the 
surrounding tissue, and distinguishing between the two types of influence is not a trivial 
exercise. Aiming to overcome this problem, we combined in vivo experiments with co-
incubation of the same metallic stents with epithelial and fibroblast cell lines in vitro.  
All stents induced significantly higher IL-8 levels in culture compared to controls, with the 
Wallstent group generating the most IL-8, which agreed with our in vivo data suggesting 
that composition of the stent itself was the cause of the systemic pro-inflammatory response 
observed in rabbits. We speculate that this systemic inflammation might be related to the 
release of metallic elements from the stent alloys, and also suspect that the results obtained 
in our in vitro study could be caused, at least in part, by that release (lixiviation) (27). These 
aspects deserve further investigation in the future. 
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Limitations of the study  
The high rate of complications found with the paclitaxel eluting stent was probably related 
to the high and fast delivery of this drug to the surrounding tracheal tissue. Establishing the 
correct dosage for specific tissue targets is therefore important (28). A previous in vitro 
study from our group suggested that cell viability could be better preserved using a 
paclitaxel-delivering stent with a dose delivery of 1 µg/mm2, rather than the 3 µg/mm2 
currently delivered by the Zilver PTX stent (29), then supporting the concept that too high 
doses of paclitaxel have played a critical role in the destructive patterns that we observed 
with this stent implanted on rabbits. Using stents in conjunction with other anti-proliferative 
drugs (29,30) might represent plausible alternatives, and drug-eluting bio absorbable stents 
might also play a role in the future (31). 
 
Although performance of the in vivo experiments with stents inserted in a normal (non-
stenotic) rabbit trachea is another limitation in our study, our approach provided a uniform 
baseline status for all animals, then allowing investigation of damage caused by the stents 
themselves. Our study was performed in small animals that required narrow vascular stent 
insertion, and it could be argued that our results do not readily extrapolate to humans. We 
would agree with this, but we also believe that the combination of our in vitro and in vivo 
approaches provides relevant insights into the pathophysiological mechanisms that are 
involved in stent-associated tissue damage. 
 
CONCLUSIONS 
Metallic stents, with and without paclitaxel delivery, induced a marked pro-inflammatory 
response in the rabbit trachea. The paclitaxel-eluting nitinol stent provoked a stronger 
reaction than bare nitinol, and the cobalt-based stent had the highest pro-inflammatory 
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response. Most important, tracheal stenosis was closely associated to increase of IL-8 
expression in blood just one day after tracheal stent implantation. If extrapolated into 
humans, our findings would imply that development of stent-induced tracheal stenosis can 
be predicted in advance when a strong systemic inflammation is observed early after stent 
placement, and adequate treatment could then be applied to prevent this complication. 
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Legends for figures: 
Figure 1.  Evaluation of endoscopic aspects. Panel A, tracheal stenosis: rated from 0 
(absent) to 2 (severe); panel B, granulation tissue (polyploid-like lesions): from 0 (absent) to 
1 (present); panel C, re-epithelisation over the stent surface: rated from 0 (absent) to 3 
(complete with stent covered by thick tissue); panel D, fibrous reaction (fibrous bands): 
from 0 (absent) to 2 (severe); panel E, inflammatory aspect of the tracheal surface: from 0 
(absent) to 2 (severe); panel F, secretions in the tracheal lumen: from 0 (absent) to 2 
(severe). 
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Figure 2. Survival of rabbits. Panel A. Survival following stent implantation. Kaplan-
Meier analysis. Panel 2B: Survival of rabbits with/without stent-induced tracheal stenosis. 
Figure 3. Gene expression following stent implantation. Panel A: Tracheal lavage IL-8 
expression (fold versus control). Panel B: IL-8 expression in serial blood samples. Panel C: 
Tracheal lavage bFGF expression (fold versus control).  Panel D: bFGF expression in serial 
blood samples. (*) p0.05 and (**) p0.001.  
Figure 4.  Results of the “in vitro” study. Morphologic changes for 21 day co-cultures of 
Nuli-1 (Panel A) and MRC-5 (Panel B) cells with each stent (10X). IL-8 levels 
((pg/ml)/total cells in supernatants of Nuli-1 (Panel C) and MRC-5 (Panel D). bFGF levels 
((pg/mL)/total cells) in cell culture of Nuli-1 (Panel E) and MRC-5 (Panel F). WS, 
Wallstent chrome-cobalt super alloy; ZF, Zilver Flex, nickel-titanium (nitinol) alloy; PTX, 
Zilver PTX (nitinol covered with paclitaxel, 3 µg/mm2); control, cell culture with no stent.  
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Table 1. Findings at tracheoscopy for the Wallstent, Zilver Flex, Zilver PTX and control 
groups. 
Findings at 
tracheoscopy 
Wallstent Zilver Flex Zilver PTX Control 
Stenosis 1±0.1** 0.2±0.1 0.7±0.3* 0 
Granulation 
tissue 
0.7±0.2* 0,6±0.2* 0.6±0.2* 0 
Re-epithelisation 1±0.1** 2±0.1** 2.5±0.2** 0 
Fibrous bands 0 0.3±0.2 1.4±0.3** 0 
Inflammation 1.9±0.1** 
 
1.2±0.1** 
 
1.6±0.2** 
 
0 
Secretions 1.6±0.2** 
 
0.9±0.2** 
 
0.6±0.3 
 
0 
Survival (mean ± 
SEM, days) 
43.4±10** 
 
75.3±10.3 
 
61.3±11.9 
 
88.6±2 
 
Survival (median 
and outliers) 
 
46 (8-90)** 90 (5-90) 84 (1-90) 90(73-90) 
Tracheal stenosis: rated from 0 (absent) to 2 (severe); granulation tissue (polyploid like 
lesions): from 0 (absent) to 1 (present); re-epithelisation over the stent surface: rated from 0 
(absent) to 3 (complete with stent covered by thick tissue); fibrous reaction (fibrous bands): 
from 0 (absent) to 2 (severe); inflammatory aspect of the tracheal surface: from 0 (absent) to 
2 (severe); secretions in the tracheal lumen: from 0 (absent) to 2 (severe). Scores are 
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presented as mean ± SEM, unless otherwise stated. (*) Statistical differences (p < 0.05); (**) 
Statistical differences (p < 0.01). 
 
Figure 1.  Evaluation of endoscopic aspects. Panel A, tracheal stenosis: rated from 0 
(absent) to 2 (severe); panel B, granulation tissue (polyploid-like lesions): from 0 (absent) to 
1 (present); panel C, re-epithelisation over the stent surface: rated from 0 (absent) to 3 
(complete with stent covered by thick tissue); panel D, fibrous reaction (fibrous bands): 
from 0 (absent) to 2 (severe); panel E, inflammatory aspect of the tracheal surface: from 0 
(absent) to 2 (severe); panel F, secretions in the tracheal lumen: from 0 (absent) to 2 
(severe). 
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Figure 2. Survival of rabbits. Panel A. Survival following stent implantation. Kaplan-
Meier analysis. Panel 2B: Survival of rabbits with/without stent-induced tracheal stenosis. 
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Figure 3. Gene expression following stent implantation. Panel A: Tracheal lavage IL-8 
expression (fold versus control). Panel B: IL-8 expression in serial blood samples. Panel C: 
Tracheal lavage bFGF expression (fold versus control).  Panel D: bFGF expression in serial 
blood samples. (*) p0.05 and (**) p0.001.  
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Figure 4.  Results of the “in vitro” study. Morphologic changes for 21 day co-cultures of 
Nuli-1 (Panel A) and MRC-5 (Panel B) cells with each stent (10X). IL-8 levels 
((pg/ml)/total cells in supernatants of Nuli-1 (Panel C) and MRC-5 (Panel D). bFGF levels 
((pg/mL)/total cells) in cell culture of Nuli-1 (Panel E) and MRC-5 (Panel F). WS, 
Wallstent chrome-cobalt super alloy; ZF, Zilver Flex, nickel-titanium (nitinol) alloy; PTX, 
Zilver PTX (nitinol covered with paclitaxel, 3 µg/mm2); control, cell culture with no stent. 
 
